Source: Business Wire

Press Release: Wockhardt : Global Market for Erythropoietin Worht USD 7.8 Billion by 2020 - Analysis, Technologies & Forecast Report 2015-2020 - Key Vendors: 3S Bio, Amgen, Novartis - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Market for Erythropoietin: 2015-2020" report to their offering. This market research report explain current market for erythropoietin drugs in terms of value. The report also highlights the major drivers and challenges, including their profiles related to erythropoietin drugs. The global market for erythropoietin drugs has been growing at a CAGR (2015 to 2020) of 1.0% driven by the increasing cases of anemia

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Habil Khorakiwala's photo - Founder & CEO of Wockhardt

Founder & CEO

Habil Khorakiwala

CEO Approval Rating

81/100

Wockhardt is a pharmaceutical and biotechnology firm that manufactures injectables and lyophilised products. Read more